Related Experiment Video
Updated: Jul 2, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Primary cancer prevention for cancers with no known infectious etiology: Time for a new paradigm
Steven Black1, Mack Roach2, Rino Rappuoli3
1University of Cincinnati, Cincinnati, USA.
Abstract:
Vaccines developed for hepatitis B and human papilloma virus infections have been very successful in reducing the burden of cancer due to these infections. In the past decade, our understanding of the immunology of cancer has greatly improved and important progress has been made in the use of immunotherapy for several cancers. However, for the majority of cancers, an infectious etiology is either unknown or does not exist. Prostate cancer, for which no infectious etiology is known, is the most common cancer in men in the United States. Here we discuss the rationale for developing a preventive vaccine for prostate cancer, discuss a possible approach for further work in this area and a means of testing the effectiveness of a prostate cancer prevention vaccine in a clinical trial.
Insights
Preventive vaccines for cancers like hepatitis B and human papilloma virus have succeeded. This research explores developing a novel prostate cancer prevention vaccine, given its high incidence in men.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Background:
- Vaccines targeting hepatitis B virus and human papilloma virus have significantly reduced cancer incidence.
- Advances in cancer immunology and immunotherapy have shown promise for treating various cancers.
- Most cancers lack a known infectious cause; prostate cancer is the most common cancer in US men with no identified infectious etiology.
Purpose of the Study:
- To present the rationale for developing a preventive vaccine for prostate cancer.
- To outline a potential strategy for future research in prostate cancer vaccine development.
- To propose a method for evaluating the efficacy of a prostate cancer preventive vaccine in clinical trials.
Main Methods:
- Review of existing literature on cancer vaccines and immunology.
- Conceptualization of a preventive vaccine approach for prostate cancer.
- Design considerations for a clinical trial to test vaccine effectiveness.
Main Results:
- The study provides a theoretical framework and rationale for a prostate cancer preventive vaccine.
Conclusions:
- A preventive vaccine for prostate cancer is a plausible and desirable goal.
- Further research and clinical trials are necessary to establish the efficacy of such a vaccine.
Related Concept Videos
Cancer Prevention
Some...
Preventive Healthcare Services
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mechanisms of Retrovirus-induced Cancers
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

